US Discriminates in Medicines for Minorities

People of Color (Latinos, Afro-Americans, and other minorities) in the
United States are victims of secondhand medicines and non-inclusion in
medicine research.

California legislators and the NAACP recently denounced that only 10
percent of Latinos, Blacks or Asians are included in research on
effects of medicines, which is responsible for greater mortality among
minorities.

The American Medical Association has found great disparities between
the health of Anglo-Saxons and the rest of the population caused by
failure to include other groups in research of medicines.

At the "Evidence and Impact of Medicine on Communities of Color" forum
in Los Angeles this week, Dr. Randall Maxey, an internal medical
specialist, explained, "What is good for the Anglo-Saxon organism is
not necessarily good for an Afro-American, Latino, or other group."

He added that some medicines react better on Afro-Americans but they
are not selected because they were not the majority during the testing
process."

The physician said that generally, decisions on which medicines to
produce are made based on the reaction they cause in the majority of
the population, so adequate remedies for minorities are never chosen.

The NAACP has proposed inclusion of these groups in research to close
the existing gap in mortality rates between whites and other racial
groups.

www.plenglish.com